Publications
2019
J. Gen. Virol. 100, 278-288 (2019)
2018
J. Virol. 93:01821-18 (2018)
Hum. Gene Ther. 29, A4-A4 (2018)
Antiviral Res. 161, 134-143 (2018)
Gastroenterology 156, 325-337 (2018)
Hepatology, accepted (2018)
Hepatology 68, 334A-334A (2018)
Oncotarget 9, 33947-33960 (2018)
J. Hepatol. 69, 1231-1241 (2018)
Mol. Ther. Nucleic Acids 12, 242-253 (2018)
J. Innate Immun. 10, 339–348 (2018)
J. Virol. 25, 17-17 (2018)
J. Virol. 25, 47-47 (2018)
J. Virol. 25, 52-53 (2018)
J. Biol. Chem. 293, 13191-13203 (2018)
J. Virol. 92:13 e00403-18 (2018)
MMW-Fortschr. Med. 160, 35-37 (2018)
GigaScience 7, 1-8 (2018)
Sci. Total Environ. 637-638, 1400-1412 (2018)
Virus Res. 251, 86-90 (2018)
J. Virol. 92, e00164-18 (2018)
Curr. Opin. Virol. 30, 58-67 (2018)
Front. Microbiol. 9:1110 (2018)
Front. Immunol. 9:1035 (2018)
Nat. Immunol. 19, 222-232 (2018)
J. Virol. 92:e02232-17 (2018)
PLoS Pathog. 14:e1006771 (2018)
Nat. Commun. 9:887 (2018)
Oncol. Res. Treat. 41, 130-130 (2018)
Cancer Immunol. Immunother. 67, 663-674 (2018)
Antiviral Res. 151, 4-7 (2018)
J. Virol. 92:e01451-17 (2018)
Glia 66, 413-427 (2018)
2017
Eur. J. Immunol. 47, 83-83 (2017)
Eur. J. Immunol. 47, 79-79 (2017)
Hum. Gene Ther. 28, A30-A30 (2017)
Cancer Immunol. Res. 5 (2017)
Proc. Natl. Acad. Sci. U.S.A. 114, 2729-2734 (2017)
J. Exp. Med. 214, 905-917 (2017)
Methods Mol. Biol. 1540, 59-72 (2017)
Transplantation 101, 904-909 (2017)
Front. Microbiol. 8, 2192 (2017)
J. Virol. 92:e01154-17 (2017)
Sci. Rep. 7:15453 (2017)
J. Int. AIDS Soc. 20:21865 (2017)
Philos. Trans. R. Soc. B - Biol. Sci. 372:20160274 (2017)
Cancer Cell 32, 342-359.e10 (2017)
Eur. J. Immunol. 47, 1342-1353 (2017)
J. Immunol. Res. 2017:3104719 (2017)
Cell. Mol. Gast. Hept. 4, 339-363 (2017)
J. Hepatol. 67, 471–479 (2017)
Eur. J. Neurol. 24, 1062-1070 (2017)
Curr. Opin. Virol. 24, 38-45 (2017)
Gut 67, 1124-1134 (2017)
Cancer Cell 31, 771-789.e6 (2017)
Nat. Rev. Gastroenterol. Hepatol. 14, 327-328 (2017)
J. Hepatol. 66, S112-S112 (2017)
J. Hepatol. 66, S29-S30 (2017)
Clin. Infect. Dis. 64, 513-516 (2017)
J. Immunol. Res. 2017:4828936 (2017)
In: (Molecular chaperones in cancer, 2-4 May 2017, Madrid). 2017. S. 51
Viruses 9:18 (2017)
Int. J. Cancer 141, 816-828 (2017)
Curr. Opin. Virol. 23, 75-81 (2017)
Front. Microbiol. 8:219 (2017)
New J. Chem. 41, 212-224 (2017)
J. Hepatol. 66, 494-503 (2017)
2016
J. Hepatol. 64, S398-S398 (2016)
J. Hepatol. 64, S361-S361 (2016)
J. Hepatol. 64, S312-S313 (2016)
Eur. J. Immunol. 46, 1, 339-339 (2016)
FEBS J. 283, 24-24 (2016)
Gastroenterology 151, 780-783 (2016)
J. Exp. Med. 213, 3075-3086 (2016)
Hepatology 63, 1, 921A-921A (2016)
Hepatology 63, 1, 257A-258A (2016)
Nat. Commun. 7:13171 (2016)
MedChemComm 7, 1797-1801 (2016)
Cancer Cell 30, 533-547 (2016)
Gastroenterology 151, 805-806 (2016)
Arab. J. Gastroenterol. 17, 111-112 (2016)
München, Technische Universität, Fakultät Wissenschaftszentrum Weihenstephan, Diss., 2016, 166 S.
München, Technische Universität, Fakultät für Medizin, Diss., 2016, 140S.
München, Technische Universität, Fakultät für Medizin, Diss., 2016, 128 S.
J. Virol. 90, 10558-10573 (2016)
Cell Death Dis. 7:e2342 (2016)
Cancer Res. 76, 5550-5561 (2016)
J. Clin. Invest. 126, 2919-2932 (2016)
Blood 128, 1829-1833 (2016)
Cancer Cell 30, 308-323 (2016)
Gastroenterology 151, 999-1010.e3 (2016)
EMBO Mol. Med. 8, 1082-1098 (2016)
EMBO J. 35, 1730-1744 (2016)
Cancer Cell 30, 75-91 (2016)
Cancer Cell 30, 15-17 (2016)
J. Virol. 90, 8954-8967 (2016)
Open Biol. 6:160046 (2016)
Lab. Med. 40, 155-164 (2016)
Cell Host Microbe 20, 36-48 (2016)
Hepatology 64, 746-759 (2016)
Cytotherapy 18, S15-S16 (2016)
J. Transl. Med. 14:175 (2016)
Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance.
Leukemia 30, 1520-1530 (2016)
J. Hepatol. 64, S49-S59 (2016)
J. Hepatol. 64, S41-S48 (2016)
Oncol. Res. Treat. 39, 16 (2016)
Oncol. Res. Treat. 39, 81 (2016)
Tumor-necrosis factor impairs CD4+ T cell-mediated immunological control in chronic viral infection.
Nat. Immunol. 17, 593-603 (2016)
Nature 531, 253-257 (2016)
FEBS J. 283, 1669-1688 (2016)
Hepatology 63, 1888-1899 (2016)
Hepatology 63, 1592-1607 (2016)
Antivir. Ther. (Lond.) 20, 779-787 (2016)
Am. J. Transplant. 16, 484-496 (2016)
Leuk. Lymphoma 57, 623-627 (2016)
Oncogene 35, 3125-3138 (2016)
J. Gen. Virol. 97, 121-127 (2016)
2015
München, Technische Universität, Fakultät für Medizin, Diss., 2015, 158 S.
München, Technische Universität, Fakultät für Medizin, Diss., 2015, 91 S.
Hepatology 62, 1244A (2015)
München, Ludwig-Maximilians-Universität, Fakultät für Biologie, Diss., 2015, 146 S.
Open Forum Infect. Dis. 2:ofv124 (2015)
Proc. Natl. Acad. Sci. U.S.A. 112, 13982-13987 (2015)
München, Technische Universität, Fakultät für Medizin, Diss., 2015, 225 S.
Cell Host Microbe 18, 409-423 (2015)
mSphere 1:e00014-15 (2015)
mSphere 1:e00015-15 (2015)
Nat. Immunol. 16, 1235-1244 (2015)
Curr. Opin. Virol. 14, 109-115 (2015)
J. Virol. 89, 12518-12524 (2015)
J. Virol. 90, 930-946 (2015)
J. Hepatol. 62, S555-S556 (2015)
J. Hepatol. 62, S526 (2015)
Cytokine 76, 108 (2015)
Kidney Int. 89, 113–126 (2015)
Gastroenterology 150, 194-205 (2015)
J. Clin. Invest. 125, 3891-3903 (2015)
München, Technische Universität, Fakultät für Medizin, Diss., 2015, 151 S.
München, Technische Universität, Fakultät für Medizin, Diss., 2015, 145 S.
München, Technische Universität, Fakultät für Medizin, Diss., 2015, 91 S.
Viruses 7, 4854-4877 (2015)
Nat. Rev. Gastroenterol. Hepatol. 12, 558-559 (2015)
Nat. Cell Biol. 17, 1205-1217 (2015)
Clin. Cancer Res. 21, 4254-4256 (2015)
J. Virol. 89, 9281-9287 (2015)
J. Virol. 89, 9178-9188 (2015)
Gastroenterology 149, 1042-1052 (2015)
Cell Death Differ. 22, 2020-2033 (2015)
A new model for post-integration latency in macroglial cells to study HIV-1 reservoirs of the brain.
Aids 29, 1147-1159 (2015)
Mol. Cell. Proteomics 14, 2085-2102 (2015)
J. Crohns Colitis 9, S104 (2015)
Eur. J. Cancer 51, S2 (2015)
J. Clin. Invest. 125, 2445-2457 (2015)
EMBO J. 34, 1612-1629 (2015)
Endocr. Metab. Immune Disord. Drug Targets 15, 105-118 (2015)
Oncotarget 6, 3462-3470 (2015)
Parasite Immunol. 37, 97-104 (2015)
J. Virol. 89, 3247-3255 (2015)
Med. Microbiol. Immunol. 204, 95-102 (2015)
J. Virol. 98, 2698-2709 (2015)
J. Hepatol. 62, 863-870 (2015)
Mod. Pathol. 28, 523-532 (2015)
Int. J. Cancer 136, 2304-2315 (2015)
Clin. Cancer Res. 21, 1951-1961 (2015)
Hepatology 61, 238-248 (2015)
2014
München, Technische Universität, Fakultät für Medizin, Diss., 2014, 116 S.
Curr. Protoc. Pharmacol. 67, 14.31.1-14.31.17 (2014)
München, Technische Universität, Fakultät für Medizin, Diss., 2014, 130 S.
Gießen, Justus-Liebig-Universität, Fakultät für Biologie und Chemie, Diss., 2014, 115 S.
Eur. J. Cancer 50, S121 (2014)
Eur. J. Cancer 50, S88 (2014)
München, Technische Universität, Fakultät für Medizin, Diss., 2014, 142 S.
München, Technische Universität, Fakultät Wissenschaftszentrum Weihenstephan, Diss., 2014, 147 S.
Biomacromolecules 15, 2058-2066 (2014)
Cell Rep. 9, 1292-1305 (2014)
Nat. Immunol. 15, 1079-1089 (2014)
J. Hepatol. 61, 600-608 (2014)
München, Technische Universität, Fakultät für Medizin, Diss., 2014, 112 S.
EMBO Mol. Med. 6, 1062-1074 (2014)
Med. Sci. (Paris) 30, 724-726 (2014)
Methods Mol. Biol. 1193, 213-226 (2014)
JAIDS 65, 53 (2014)
Virology 464-465, 375-384 (2014)
Trends Pharmacol. Sci. 35, 470-478 (2014)
J. Neurosci. 34, 10264-10273 (2014)
Biophys. J. 106, 465A (2014)
Blood 124, 1393-1403 (2014)
Sci. Transl. Med. 6:242ra81 (2014)
Virology 458-459, 183-189 (2014)
Cell Rep. 7, 1796-1808 (2014)
Mucosal Immunol. 7, 1452-1466 (2014)
München, Technische Universität, Fakultät für Medizin, Diss., 2014, 135 S.
Mol. Cell. Proteomics 13, 1676-1689 (2014)
Nat. Immunol. 15, 538-545 (2014)
Viruses 6, 1654-1671 (2014)
PLoS ONE 9:e95779 (2014)
Cell Host Microbe 15, 249-250 (2014)
Acta Neuropathol. Commun. 2:27 (2014)
Science 343, 1221-1228 (2014)
Cytokine Growth Factor Rev. 25, 125-137 (2014)
Hepatology 59, 2110-2120 (2014)
The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitor.
PLoS ONE 9:e87487 (2014)
Br. J. Cancer 110, 686-694 (2014)
J. Gastroenterol. Hepatol. 29, 1083-1091 (2014)
2013
München, Technische Universität, Fakultät für Medizin, Diss., 2013, 151 S.
Hepatology 58, 274A-275A (2013)
Retrovirol. 10:137 (2013)
Faraday Discuss. 161, 31-43 (2013)
Science 342, 1243-1246 (2013)
J. Hepatol. 58, S57 (2013)
München, Ludwig-Maximilians-Universität, Tierärztliche Fakultät, Diss., 2013, 115 S.
Nat. Neurosci. 16, 1618-1626 (2013)
Oncogene 33, 3217-3224 (2013)
Retrovirol. 10:132 (2013)
PLoS ONE 8:e76281 (2013)
J. Clin. Virol. 58, 24-30 (2013)
Oncotarget 4, 1117-1118 (2013)
PLoS ONE 8:e69691 (2013)
Dig. Dis. 31, 138-151 (2013)
Am. J. Physiol. Endocrinol. Metab. 304, E1140-E1156 (2013)
Virology 440, 190-203 (2013)
Gastroenterology 145, 456-465 (2013)
J. Virol. 87, 4360-4371 (2013)
Nat. Neurosci. 16, 273-280 (2013)
Cytometry A 83, 182-184 (2013)
J. Virol. 87, 1491-1496 (2013)
Antiviral Res. 97, 195-197 (2013)
2012
Köln, Universität, Medizinische und Mathematisch-Naturwissenschaftliche Fakultät, Diss., 2012, 176 S.
Dig. Liver Dis. 44, S4 (2012)
Retrovirus-Bull. 4, 4-6 (2012)
München, Technische Universität, Fakultät Wissenschaftszentrum Weihenstephan, Diss., 2012, 103 S.
München, Technische Universität, Fakultät Wissenschaftszentrum Weihenstephan, Diss., 2012, 147 S.
München, Technische Universität, Fakultät Wissenschaftszentrum Weihenstephan, Diss., 2012, 125 S.
München, Technische Universität, Fakultät Wissenschaftszentrum Weihenstephan, Diss., 2012, 157 S.
PLoS Pathog. 8:e1002867 (2012)
Cell 150, 194-206 (2012)
BMC Microbiol. 12:307 (2012)
PLoS ONE 7:e49341 (2012)
Gastroenterology 143, 1361-1374 (2012)
J. Natl. Cancer Inst. 104, 1796-1807 (2012)
Dig. Dis. 30, 453-468 (2012)
Retrovirol. 9:82 (2012)
J. Cell Biol. 199, 467-479 (2012)
Oncotarget 3, 919-920 (2012)
Cell Rep. 2, 478-487 (2012)
München, Technische Universität München, Fakultät Wissenschaftszentrum Weihenstephan, Diss., 2012, 160 S.
Angew. Chem.-Int. Edit. 51, 8110-8113 (2012)
J. Clin. Virol. 55, 114-120 (2012)
A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.
J. Infect. Dis. 205, 1654-1664 (2012)
Influence of antipsychotic drugs on Human Endogenous Retrovirus (HERV) transcription in brain cells.
PLoS ONE 7:e30054 (2012)
J. Cell. Mol. Med. 16, 59-71 (2012)
PLoS ONE 7:e34812 (2012)
J. Immunol. 188, 5824-5828 (2012)
Gastroenterology 142, 1447-1450 (2012)
Infect. Genet. Evol. 12, 461-466 (2012)
Proc. Natl. Acad. Sci. U.S.A. 109, 6259-6264 (2012)
J. Virol. 86, 2826-2836 (2012)
Nat. Rev. Immunol. 12, 201-213 (2012)
J. Immunol. 188, 615-623 (2012)
J. Immunol. Methods 375, 46-56 (2012)
Microb. Biotechnol. 5, 270-282 (2012)
2011
Circulation 124, 175-184 (2011)
Am. J. Physiol. Gastrointest. Liver Physiol. 300, G968-G975 (2011)
In: Gendelmann, H.E.* [Eds.]: The Neurology of Aids. New York, NY: Oxford Univ. Press, 2011. 275-288
Swiss Med. Wkly. 141:w13287 (2011)
PLoS ONE 6:e27618 (2011)
J. Agric. Food Chem. 59, 12893-12901 (2011)
München, Technische Universität München, Fakultät Wissenschaftszentrum Weihenstephan, Diss., 2011, 107 S.
München, Technische Universität, Fakultät Wissenschaftszentrum Weihenstephan, Diss., 2011, 175 S.
München, Ludwig-Maximilian-Universität, Fakultät für Biologie, Diss., 2011, 138 S.
München, Technische Universität, Fakultät Wissenschaftszentrum Weihenstephan, Diss., 2011, 96 S.
München, Ludwig-Maximilians-Universität, Fakultät für Biologie, Diss., 2011, 126 S.
J. Hepatol. 54, S33-S34 (2011)
PLoS ONE 7:e1001257 (2011)
Nature 479, 547-551 (2011)
PLoS ONE 6:e26315 (2011)
Dig. Dis. 29, 423-433 (2011)
Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection.
J. Hepatol. 55, 996-1003 (2011)
Future Virol. 6, 599-614 (2011)
J. Gen. Virol. 92, 2356-2366 (2011)
Swiss Med. Wkly. 141:w13197 (2011)
Virol. J. 8:35 (2011)
BMC Biotechnol. 11:4 (2011)
J. Neural Transm. 118, 737-745 (2011)
J. Immunol. 187, 3186-3197 (2011)
J. Immunol. 186, 6718-6725 (2011)
Adv. Exp. Med. Biol. 691, 231-249 (2011)
J. Hepatol. 54, S49 (2011)
Int. J. Cancer 128, 2353-2363 (2011)
J. Viral Hepat. 18, 216-226 (2011)
2010
Cancer Cell 17, 481-496 (2010)
Gene Ther. 17, 1191-1192 (2010)
In: Daniel, R.* ; Hejnar, J.* ; Skalka, A.M.* ; Svoboda, J.* [Eds.]: Proceedings (Centennial Retrovirus Meeting, 29th April - 4th May 2010, Prague, Czech Republic). Bologna: Medimond, 2010. 39-43
München, Technische Universität München, Fakultät Wissenschaftszentrum Weihenstephan, Diss., 2010, 191 S.
München, Ludwig-Maximilians-Universität München, Fakultät für Chemie und Pharmazie, Diss., 2010, 105 S.
Oncotarget 1, 373-378 (2010)
Future Microbiol. 5, 221-239 (2010)
J. Med. Virol. 82, 446-451 (2010)
Hepatology 51, 1954-1960 (2010)
J. Med. Virol. 82, 1058-1064 (2010)
Science 330, 980-982 (2010)
Science 328, 1705-1709 (2010)
PLoS Pathog. 6:e1001097 (2010)
Vortrag: 9th GfV-Workshop on Immunobiology of Viral Infections, 6-8 October 2010, Deidesheim. (2010)
Vortrag: HiT2010, 04 November 2010, Moskau. (2010)
Vortrag: 2010 International Meeting on Molecular Biology of Hepatitis B Viruses, 09-13 Oktober 2010, Taipeh, Taiwan. (2010)
Vortrag: 2010 International Meeting on Molecular Biology of Hepatitis B Viruses, 09-13 Oktober 2010, Taipeh, ROC. (2010)
Vortrag: 2010 International Meeting on Molecular Biology of Hepatitis B Viruses, 09-13 Oktober 2010, Taipei, Taiwan. (2010)
Vortrag: Molecular Biology of Hepatitis B Viruses, 09 Oktober 2010, Taipei, Taiwan. (2010)
Vortrag: 14th International Congress of Immunology, 22-27 August 2010, Kobe, Japan. (2010)
Vortrag: XVIIIth International Poxvirus, Asfivirus and Iridovirus Symposium, 5-10 June 2010, Sedona (AZ), USA. (2010)
Vortrag: 4th European Congress of Virology, 07-11 April 2010, Cernobbio, Como Lake, Italy. (2010)
Med. Hypotheses 75, 99-105 (2010)
J. Virol. 84, 11994-12001 (2010)
J. Viral Hepat. 17, 527-536 (2010)
Hepat. Res. Treat. 2010:901216 (2010)
J. Biol. Chem. 285, 6198-6207 (2010)
Z. Gastroenterol. 48, 289-351 (2010)
Hepatology 51, 1430-1437 (2010)
Aids Res. Ther. 7, 20 (2010)
PLoS ONE 5:e11400 (2010)
Antimicrob. Agents Chemother. 54, 5257-5268 (2010)
J. Gen. Virol. 91, 1503-1513 (2010)
J. Biol. Chem. 285, 28893-28901 (2010)
Chromosome Res. 18, 401-417 (2010)
Biopolymers 93, 740-751 (2010)
Naunyn-Schmiedebergs Arch. Pharmakol. 381, 541-553 (2010)
Eur. J. Immunol. 40, 494-504 (2010)
2009
Hepatology 50, 1773-1782 (2009)
Immunol. Lett. 123, 31-37 (2009)
In: Kräusslich, H.G.* ; Bartenschlager, R.* [Eds.]: Antiviral Strategies.. Berlin: Springer, 2009. 265-297 (Handb. Exp. Pharmacol. ; 189)
J. Biol. Chem. 284, 33384-33391 (2009)
Protein Eng. Des. Sel. 22, 753-763 (2009)
J. Immunol. 183, 6898-6902 (2009)
In: Ovesen, K.* ; Matthiesen, O.* [Eds.]: DNA Fingerprinting, Sequencing and Chips. New York, NY: Nova Science Publishers, 2009. 87-118
Inhibition of HBV replication by RIG-I stimulation with 5`-triphosphated siRNA in vitro and in vivo.
Köln, Universität zu Köln, Mathematisch-Naturwissenschaftliche Fakultät, Diss., 2009, 171 S.
München, Ludwig-Maximilian-Universität, Fakultät für Biologie, Diss., 2009, 143 S.
München, Ludwig-Maximilians-Universität, Fakultät für Biologie, Diss., 2009, 141 S.
München, Ludwig-Maximilians-Universität, Fakultät für Biologie, Diss., 2009, 127 S.
Vortrag: 8th Workshop on Imunology of Viral Infections, GfV, 7-9 October 2009, Deidesheim, Germany. (2009)
Vortrag: International Meeting 2009, 30th August - 02nd September 2009, Tour, France. (2009)
Vortrag: 34th Annual Meeting on Retroviruses in CSHL, 17th May 2009, CSHL, NY, USA. (2009)
Vortrag: 19th Annual Meeting of the Society for Virology (GfV), 18- 21 March 2009, Leipzig, Germany. (2009)
Vortrag: FASEB Summer Research Conference Mobile Elements in Mammalian Genomes, 05-10 July 2009, Colorado, USA. (2009)
Methods Mol. Biol. 530, 463-509 (2009)
J. Virol. 83, 12643-12650 (2009)
J. Biol. Chem. 284, 31260-31269 (2009)
J. Virol. 83, 11616-11623 (2009)
PLoS ONE 4:e4155 (2009)
J. Virol. Methods 156, 37-43 (2009)
J. Exp. Med. 206, 549-559 (2009)
Gene Ther. 16, 349-358 (2009)
Transgenic Res. 18, 71-87 (2009)
2008
Int. J. Hyperthermia 24, 623-637 (2008)
J. Immunol. 181, 6371-6383 (2008)
München, Ludwig-Maximilians-Universität, Fakultät für Biologie, Diss., 2008, 159 S.
J. Virol. 82, 1908-1922 (2008)
J. Viral Hepat. 15, (Suppl.1), 1-20 (2008)
Gastroenterology 134, 239-247 (2008)
Antimicrob. Agents Chemother. 52, 2355-2359 (2008)
Cell. Microbiol. 10, 1478-1490 (2008)
In: Weber, O.* ; Protzer, U.* [Eds.]: Comparative Hepatitis. Basel: Birkhäuser, 2008. 75-93
Blood 111, 4653-4659 (2008)
J. Virol. 82, 1808-1818 (2008)
Methods Mol. Biol. 384, 751-769 (2008)
J. Gene Med. 10, 177-186 (2008)
FASEB J. 22, 437-444 (2008)
2007
In: Méndez-Vilas, A.* ; Díaz, J.* [Eds.]: Modern Research and Educational Topics in Microscopy, Volume 2. Badajoz, Spain: Formatex, 2007. 863-872
Z. Gastroenterol. 45, 1281-1328 (2007)
In: Modern Research and Educational Topics in Microscopy. Formatex, 2007. 863-872
München, Technische Universität München, Fakultät für Medizin, Diss., 2007, 122 S.
World J. Gastroenterol. 13, 65-73 (2007)
Leukemia 21, 936-942 (2007)
J. Virol. 81, 3608-3617 (2007)
J. Virol. 81, 10588-10596 (2007)
Gastroenterology 133, 1156-1165 (2007)
Dtsch. Med. Wochenschr. 132, 1775-1782 (2007)
München, Ludwig-Maximilians-Universität, Fakultät für Biologie, Diss., 2007, 169 S.
J. Viral Hepat. 14, (Suppl.1), 45-50 (2007)
EMBO Rep. 8, 945-951 (2007)
J. Exp. Med. 204, 2187-2198 (2007)
J. Virol. 81, 11925-11936 (2007)
Infect. Agents Cancer 2:14 (2007)
Aids 21, 2271-2281 (2007)
Eur. J. Immunol. 37, 315-327 (2007)
2006
Exp. Cell Res. 312, 3659-3668 (2006)
J. Cell Sci. 119, 4520-4530 (2006)
BioTechniques 41, 688-692 (2006)
Ultrastruct. Pathol. 30, 187-192 (2006)
BioTechniques 41, 1 (2006)
J. Virol. 80, 4415-4421 (2006)
Das murine Gammaherpesvirus 68 als in vivo Modell zur Evaluierung von Antigen-spezifischen Vakzinen.
München, Technische Universität, Fakultät Wissenschaftszentrum Weihenstephan, Diss., 2006, 149 S.
Tierarztl. Prax. Ausg. K Kleintiere Heimtiere 3, 178-184 (2006)
J. Virol. 80, 4187-4190 (2006)
Overexpression of STAT-1 by adenoviral gene transfer does not inhibit hepatitis B virus replication.
Eur. J. Gastroenterol. Hepatol. 18, 167-174 (2006)
Hepatology 43, 539-547 (2006)
Biochem. Biophys. Res. Commun. 343, 825-831 (2006)
J. Infect. Dis. 194, 1447-1449 (2006)
J. Gen. Virol. 87, 2917-2921 (2006)
Mol. Phylogenet. Evol. 40, 620-627 (2006)
J. Virol. 80, 4415-4421 (2006)
Genetics 172, 733-741 (2006)
2005
Aids Res. Hum. Retrovir. 21, 940-944 (2005)
München, Ludwig-Maximilians-Universität, Diss., 2005, 175 S.
Klinikarzt 34, 337-341 (2005)
BMC Evol. Biol. 5:49 (2005)
Virology 343, 171-178 (2005)
Microbes Infect. 7, 1400-1404 (2005)
J. Virol. 79, 13412-13420 (2005)
Virus Res. 111, 194-213 (2005)
BMC Cell Biol. 6:20 (2005)
Nucleic Acids Res. 33, 5139-5144 (2005)
Tierarztl. Prax. Ausg. K Kleintiere Heimtiere 33, 334-340 (2005)
Blood 105, 3263-3269 (2005)
J. Virol. 79, 10890-10901 (2005)
Virology 334, 203-213 (2005)
Cancer Immunol. Immunother. 54, 453-467 (2005)
Int. J. Cancer 116, 944-948 (2005)
Cytogenet. Genome Res. 110, 553-558 (2005)
J. Mol. Biol. 349, 487-500 (2005)
2004
BioSpektrum 6, 796-798 (2004)
Innsbruck, Leopold-Franzens-Universität, Diss., 2004, 80 S.
Curr. Opin. Biotechnol. 15, 506-512 (2004)
Hum. Mol. Genet. 13, 1535-1549 (2004)
BMC Evol. Biol. 4:38 (2004)
Methods Mol. Med. 95, 189-198 (2004)
Virus Res. 106, 199-209 (2004)
Immunol. Lett. 91, 155-158 (2004)
Methods Mol. Med. 96, 209-218 (2004)
Hum. Gene Ther. 15, 203-210 (2004)
J. Virol. 78, 4566-4572 (2004)
München, Ludwig-Maximilians-Universität, Fakultät für Biologie, Diss., 2004, 144 S.
Cancer Res. 64, 215-220 (2004)
Int. J. Cancer 108, 571-579 (2004)
Methods Mol. Biol. 269, 77-99 (2004)
In: Sverdlov, E.* [Eds.]: Retroviruses and Primate Genome Evolution. Georgetown, TX: Landes Bioscience, 2004. 123-143
2003
München, Ludwig-Maximilians-Universität, Diss., 2003, 209 S.
München, Ludwig-Maximilians-Universität, Diss., 2003, 132 S.
Exp. Cell Res. 291, 484-509 (2003)
Cancer Res. 63, 4107-4111 (2003)
J. Hepatol. 38, 736-744 (2003)
Methods Mol. Med. 87, 51-68 (2003)
J. Virol. Methods 112, 79-91 (2003)
Curr. Drug Targ. - Infect. Disord. 3, 263-271 (2003)
Nucleic Acids Res. 31, 2839-2851 (2003)
Neuropathol. Appl. Neurobiol. 29, 378-388 (2003)
J. Virol. 77, 4635-4645 (2003)
Ultrastruct. Pathol. 27, 49-53 (2003)
J. Immunol. 170, 270-278 (2003)
BioTechniques 34, 694-700 (2003)
Proc. Natl. Acad. Sci. U.S.A. 100, 217-222 (2003)
J. Clin. Microbiol. 41, 1811-1818 (2003)
2002
J. Immunol. 169, 4511-4521 (2002)
Biochemistry 41, 9208-9214 (2002)
In: Recent research developments in virology. 2002. 77-86 ( ; 4)
Vaccine 20, 2921-2927 (2002)
J. Virol. Methods 106, 141-151 (2002)
J. Immunol. Methods 259, 95-110 (2002)
J. Virol. 76, 4108-4112 (2002)
In: Tooke, J.* ; Shore, A.* ; Whatmore, J.* [Eds.]: Proceedings (22. Meeting of the European Society for Microcirculation : The Microcirculation and Vascular Biology, Exeter, UK, 28.08. - 30.0). Bologna: Monduzzi Editore, 2002. 215-219
2001
Virology 279, 280-291 (2001)
Genome Res. 11, 333-340 (2001)
Eur. J. Cancer 37, 1251-1269 (2001)
Aids Res. Hum. Retrovir. 17, 1035-1039 (2001)
BIOforum 5, 328-331 (2001)
Adv. Cancer Res., 125-159 (2001)
J. Virol. 75, 7161-7174 (2001)
Aids 15, 5, 139-145 (2001)
Aids Res. Hum. Retrovir. 17, 597-602 (2001)
J. Cell Sci. 114, 1717-1729 (2001)
2000
Aids Res. Hum. Retrovir. 16, 471-480 (2000)
Aids Res. Hum. Retrovir. 16, 721-729 (2000)
J. Neurovirol. 6, 75-83 (2000)
Genomics 66, 98-103 (2000)
Cancer 88, 1650-1662 (2000)
J. Immunol. 165, 509-517 (2000)
2000, 138 S. (Zugl. Tierärztliche Fakultät, LMU München, Diss., 2000)
Semin. Cancer Biol. 10, 367-381 (2000)
BioTechniques 28, 1137-1148 (2000)
1999
Immunity 10, 21-28 (1999)
NeuroAids 2, 1-7 (1999)
J. Med. Primatol. 28, 195-205 (1999)
Vaccine 17, 2713-2714 (1999)
J. Natl. Cancer Inst. 91, 1725-1733 (1999)
Adv. Enzyme Regul. 39, 331-339 (1999)
Leukemia 13 (Suppl.1), 110-112 (1999)
Int. J. Oncol. 14, 287-289 (1999)
J. Invest. Dermatol. 113, 587-594 (1999)
J. Neurosci. Res. 55, 569-577 (1999)
München, Technische Universität, Fakultät für Chemie, Diss., 1999, 155 S.
1998
München, Ludwig-Maximilians-Universität, Fakultät für Biologie, Diss., 1998, 177 S.
1998, 183 S. (Zugl. Fakultät f. Biologie, LMU-München, Diss., 1998)
J. Gen. Virol. 79, 731-740 (1998)
1996
Bioinformatics 12, 197-203 (1996)
1994
Restricted expression of HIV1 in human astrocytes: Molecular basis for viral persistence in the CNS.
Res. virol. 145, 147-153 (1994)
1993
Hum. Gene Ther. 4, 129-141 (1993)
In: Novak, J.F.* ; McMaster, J.H.* [Eds.]: Frontiers of Osteosarcoma research. Seattle (u.a.) : Hogrefe & Huber Publishers, 1993. 289-292
In: Novak, J.F.* ; McMaster, J.H.* [Eds.]: Frontiers of Osteosarcoma Research. Seattle (u.a.) : Hogrefe & Huber Publishers, 1993. 411-418
Arch. Virol. 128, 81-95 (1993)
Hum. Gene Ther. 4, 129-141 (1993)
AIDS-Forschung 8, 275-281 (1993)
FEMS Microbiol. Lett. 109, 289-296 (1993)
Nature 364, 154-158 (1993)
Res. Exp. Med. 193, 123-135 (1993)
Genomics 18, 261-269 (1993)
1992
Biochem. J. 283, 625-632 (1992)
Zbl. Pathol. 138, 97-102 (1992)
J. Gen. Virol. 73, 1087-1097 (1992)
In: Weis, S.* ; Hippius, H.* [Eds.]: HIV-1 Infection of the Central Nervous System. Clinical, Pathological, and Molecular Aspects. Seattle : Hogrefe & Huber Publ., 1992. 281-305
Leukemia 6 (Suppl.3), 158-160 (1992)
Aids 6, 1427-1436 (1992)
Influence of amphipathic peptides on the HIV-1 production in persistently infected T lymphoma cells.
FEBS Lett. 309, 235-241 (1992)
Int. J. Cancer 50, 252-258 (1992)
Leukemia 6, 72S-75S (1992)
1991
1990
Cancer Res. 50, 17, 5636s-5642s (1990)
1989
AGF Forschungsthemen 3, 19-20 (1989)
AIDS-Forschung 4, 672-675 (1989)
AIDS-Forschung 4, 609-612 (1989)
1986
AIDS-Forschung 1, 117-123 (1986)
1982
Verh. DKG 3, S. 513 (1982)